Moneycontrol PRO
HomeNewsBusinessCompaniesJubilant Life Sciences announces price hike of up to 15%

Jubilant Life Sciences announces price hike of up to 15%

We have increased price up to 15 per cent for Beta Picoline, 3-Cyanopyridine and Vitamin B3 (Niacin & Niacinamide) with immediate effect, for non-contract customers and wherever existing contracts permit," a company statement said here.

December 20, 2016 / 19:05 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Jubilant Life Sciences, a global leader in the pyridine, picolines and nutrition industry, today announced a price increase of up to 15 per cent for its select products.

    "We have increased price up to 15 per cent for Beta Picoline, 3-Cyanopyridine and Vitamin B3 (Niacin & Niacinamide) with immediate effect, for non-contract customers and wherever existing contracts permit," a company statement said here.

    Jubilant Life Sciences is engaged in pharmaceuticals, life science ingredients and drug discovery solutions.

    The pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma, is engaged in manufacture and supply of APIs, solid dosage formulations, radio-pharmaceuticals, allergy therapy products and contract manufacturing of sterile and non-sterile products through 6 USFDA approved manufacturing facilities in India, USA and Canada. PTI AP NSK .

    first published: Dec 20, 2016 06:18 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347